Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 577-581

  Coffey, Dennis C ^a,b   Kutko, Martha C ^b   Glick, Richard D ^b   Swendeman, Steven L ^a   Butler, Lisa ^a   Rifkind, Richard ^a   Marks, Paul A ^a   Richon, Victoria M ^a   LaQuaglia, Michael P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Medical Center   (United States)

Author keywords

Histone deacetylase inhibitors; Neuroblastoma; Retinoic acids

Indexed keywords

CARBOXYCINNAMIC ACID BISHYDROXAMIDE; CINNAMIC ACID DERIVATIVE; HISTONE DEACETYLASE; RETINOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CHILDHOOD CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASES; CELL DIVISION; CINNAMATES; G1 PHASE; HISTONE DEACETYLASES; HUMANS; NEUROBLASTOMA; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033646839     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<577::AID-MPO18>3.0.CO;2-3     Document Type: Conference Paper

References (27)

1. Neuroblastoma
2. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
3. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
4. Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5
5. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome
6. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
7. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway
8. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation
9. Histone acetylation in chromatin structure and transcription
10. Response of neuroblastoma to retinoic acid in vitro and in vivo
11. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma
12. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
13. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
14. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid
15. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
16. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
17. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer
18. Retinoids and the control of growth/death decisions in human neuroblastoma cell lines
19. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro
20. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbolester-induced differentiation
21. In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP
22. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
23. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation
24. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer
25. Fusion proteins of the retinoic acid receptoralpha recruit histone deacetylase in promyelocytic leukaemia
26. Role of the histone deacetylase complex in acute promyelocytic leukaemia
27. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL